Bath & Body Works, Inc. BBWI
Composite 55/100; the shares have moved about 59% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Momentum ranks 32/100 — a moderate mark against it.
Income ranks 88/100 — a strong point in its favour. Valuation ranks 86/100 — a strong point in its favour. Balance-sheet strength ranks 56/100 — a slight point in its favour.
Momentum ranks 32/100 — a moderate mark against it. Growth ranks 38/100 — a moderate mark against it. Quality ranks 48/100 — a slight mark against it.
What the company does Bath & Body Works, Inc. (BBWI) designs, manufactures, and sells personal care and home fragrance products under brands like Bath & Body Works. Its portfolio includes candles, body washes, lotions, and sanitizers sold through retail stores and e-commerce in the U.S., Canada, and internationally via franchise partners.
Key financials BBWI reports gross margins of 43.2%, operating margins of 11.0%, and net margins of 10.0%. ROA is 13.9%, ROCE 32.8%, and ROE 0.0%. Revenue declined -3.2% YoY, while EPS surged 83.7%. The company yields 4.1% with a 22.7% payout ratio and has a strong FCF yield of 18.0%.
Stock health Momentum is mixed: +4.40% over 3 months, -1.27% over 6 months, and -30.55% over 12 months. The stock is -35.87% below its 52-week high, with RSI(14) at 48.30. Sideravia scores Valuation at 83.4 and Income at 94.7, but Momentum lags at 40.3.
Price vs fair value The stock trades at a discount to both our fair-value estimate and analyst target: - Price is at a discount of 7.00% versus our fair-value estimate of 21.47. - Price is at a discount of 25.56% versus the 12-month target of 25.20 (analyst count 15.0). - Valuation percentile is high at 83.4, yet momentum and growth scores trail peers.
Looking forward Forward P/E is 6.73, EV/EBITDA 5.54. Analysts cite valuation appeal but flag growth headwinds from competitive pressure and macro sensitivity. The dividend yield of 4.1% supports income-focused interest.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.